Sujaatha Narayanan

514 total citations
43 papers, 272 citations indexed

About

Sujaatha Narayanan is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Sujaatha Narayanan has authored 43 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 16 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Sujaatha Narayanan's work include Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Sujaatha Narayanan is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Sujaatha Narayanan collaborates with scholars based in Canada, United Kingdom and Saudi Arabia. Sujaatha Narayanan's co-authors include Heather J. Sutherland, Donna L. Forrest, Stephen H. Nantel, Kevin Song, Maryse Power, Thomas J. Nevill, Donna E. Hogge, Michael J. Barnett, Cynthia L. Toze and Raewyn Broady and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Sujaatha Narayanan

36 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sujaatha Narayanan Canada	10	181	81	67	63	61	43	272
Andres Virchis United Kingdom	10	95 0.5×	90 1.1×	111 1.7×	65 1.0×	89 1.5×	15	285
Michael Heinsch Germany	8	267 1.5×	125 1.5×	88 1.3×	52 0.8×	48 0.8×	14	324
Claudia Minotto Italy	9	92 0.5×	122 1.5×	56 0.8×	110 1.7×	62 1.0×	14	252
Carlos Hader United States	5	215 1.2×	114 1.4×	67 1.0×	28 0.4×	53 0.9×	7	299
Nobuaki Dobashi Japan	9	132 0.7×	54 0.7×	69 1.0×	35 0.6×	104 1.7×	50	269
Cecilia Arana Yi United States	8	100 0.6×	71 0.9×	80 1.2×	24 0.4×	55 0.9×	21	210
Rocco Pastano Italy	10	177 1.0×	74 0.9×	80 1.2×	64 1.0×	66 1.1×	19	285
Laura Gallur Spain	6	184 1.0×	69 0.9×	13 0.2×	83 1.3×	55 0.9×	18	266
Ana Jiménez Ubieto Spain	9	68 0.4×	50 0.6×	66 1.0×	78 1.2×	95 1.6×	42	212
José Antonio Queizán Spain	7	103 0.6×	48 0.6×	74 1.1×	26 0.4×	58 1.0×	13	169

Countries citing papers authored by Sujaatha Narayanan

Since Specialization

Citations

This map shows the geographic impact of Sujaatha Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujaatha Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujaatha Narayanan more than expected).

Fields of papers citing papers by Sujaatha Narayanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujaatha Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujaatha Narayanan. The network helps show where Sujaatha Narayanan may publish in the future.

Co-authorship network of co-authors of Sujaatha Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sujaatha Narayanan. A scholar is included among the top collaborators of Sujaatha Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujaatha Narayanan. Sujaatha Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chung, Shanee, Donna L. Forrest, Florian Kuchenbauer, et al.. (2025). Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years. Transplantation and Cellular Therapy. 31(2). S50–S51.

Kuchenbauer, Florian, Ryan J. Stubbins, Shanee Chung, et al.. (2023). Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort. Blood. 142(Supplement 1). 1482–1482. 3 indexed citations

Mourad, Yasser Abou, Donna L. Forrest, Alina S. Gerrie, et al.. (2021). Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population. Clinical Lymphoma Myeloma & Leukemia. 21(7). 476–482. 2 indexed citations

Hogge, Donna E., Donna L. Forrest, Sujaatha Narayanan, et al.. (2020). Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort. Clinical Lymphoma Myeloma & Leukemia. 20(7). e427–e436. 1 indexed citations

Sutherland, Heather J., Yasser Abou Mourad, Michael J. Barnett, et al.. (2019). Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center. Clinical Lymphoma Myeloma & Leukemia. 19(12). 784–790. 12 indexed citations

Barnett, Michael J., Donna E. Hogge, Donna L. Forrest, et al.. (2018). Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis. Clinical Lymphoma Myeloma & Leukemia. 18(11). e481–e491. 9 indexed citations

Alzahrani, Musa, Maryse Power, Yasser Abou Mourad, et al.. (2018). Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience. Biology of Blood and Marrow Transplantation. 24(6). 1209–1215. 14 indexed citations

Halwani, Ahmad, Zachary Burningham, Vikas Patil, et al.. (2017). Practice patterns in metastatic castration-resistant prostate cancer (mCRPC): Evidence from the veterans health administration. Annals of Oncology. 28. v277–v278. 2 indexed citations

Lad, Deepesh, Yasser Abou Mourad, Michael J. Barnett, et al.. (2016). Pre-Transplant Vitamin D Deficiency is Associated with Inferior Overall Survival but not Associated with Relapse Free Survival or Cumulative Incidence of GVHD Post Adult Hematopoietic Cell Transplantation for Hematological Malignancies. Biology of Blood and Marrow Transplantation. 22(3). S334–S334. 1 indexed citations

10.

Kliman, David, Michael J. Barnett, Raewyn Broady, et al.. (2016). Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia. Leukemia & lymphoma. 58(4). 909–915. 3 indexed citations

11.

Nair, Anish, Michael J. Barnett, Raewyn Broady, et al.. (2015). Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors. Biology of Blood and Marrow Transplantation. 21(8). 1437–1444. 17 indexed citations

12.

Narayanan, Sujaatha, et al.. (2014). Needle Phobia And Associated Clinical Practice Patterns Among Patients With Multiple Sclerosis (Ms) In Europe And The United States. Value in Health. 17(3). A63–A63.

13.

Narayanan, Sujaatha, et al.. (2014). Characteristics of Patients With Systemic Lupus Erythematosus (Sle) Currently On Remission, With Active Disease But Not Experiencing Flare, and Those Experiencing Flares In Clinical Practices In Europe. Value in Health. 17(7). A539–A539. 1 indexed citations

14.

Lee, Moon‐Hee, Sujaatha Narayanan, Edith G. McGeer, & Patrick L. McGeer. (2014). Aurin Tricarboxylic Acid Protects against Red Blood Cell Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinemia. PLoS ONE. 9(1). e87316–e87316. 12 indexed citations

15.

Narayanan, Sujaatha, et al.. (2014). Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States. Value in Health. 17(7). A404–A405.

16.

Gerrie, Alina S., Thomas J. Nevill, Heather J. Sutherland, et al.. (2014). Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database. Blood. 124(21). 2549–2549. 1 indexed citations

17.

Tantiworawit, Adisak, Maryse Power, Michael J. Barnett, et al.. (2011). Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy. Leukemia & lymphoma. 53(7). 1321–1326. 13 indexed citations

18.

Venner, Christopher P., Joseph M. Connors, Heather J. Sutherland, et al.. (2010). Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months). Leukemia & lymphoma. 52(1). 34–41. 25 indexed citations

19.

Bareford, D., et al.. (2005). Remission induction in a Jehovah's Witness patient with acute myeloid leukaemia using gemtuzumab ozogamicin. Transfusion Medicine. 15(5). 445–448. 5 indexed citations

20.

Arnold, Douglas L., Nicola De Stefano, Sujaatha Narayanan, & Paul M. Matthews. (2000). PROTON MR SPECTROSCOPY IN MULTIPLE SCLEROSIS. Neuroimaging Clinics of North America. 10(4). 789–798. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact